Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences IncfiledCriticalGilead Sciences Inc
Publication of AR126702A1publicationCriticalpatent/AR126702A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto de la fórmula (1) o una sal farmacéuticamente aceptable de este. Una formulación farmacéutica que comprende una cantidad terapéuticamente efectiva de un compuesto de una cualquiera de las reivindicaciones anteriores, o una sal farmacéuticamente aceptable de este, y un portador o excipiente farmacéuticamente aceptable.A compound of formula (1) or a pharmaceutically acceptable salt thereof. A pharmaceutical formulation comprising a therapeutically effective amount of a compound of any one of the preceding claims, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient.
ARP220102234A2020-02-242022-08-18
PHOSPHOLIPID COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF
AR126702A1
(en)
DERIVATIVES OF QUINOLINA. PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINE
DIPHENYLHEXANE COMPOUNDS, A PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS, AND PROCEDURES FOR THE MANUFACTURE OF MEDICINES TO INHIBIT HIV INFECTION
DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE